 Daniel Kao
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella enterica | 2 | 2022 | 57 | 1.250 |
Why?
| | Colon | 3 | 2025 | 282 | 1.020 |
Why?
| | Intestinal Mucosa | 7 | 2025 | 623 | 0.860 |
Why?
| | Adenosine | 4 | 2022 | 225 | 0.820 |
Why?
| | Metabolomics | 3 | 2018 | 678 | 0.690 |
Why?
| | Fimbriae Proteins | 3 | 2009 | 21 | 0.610 |
Why?
| | 5'-Nucleotidase | 1 | 2017 | 41 | 0.550 |
Why?
| | Pseudomonas aeruginosa | 3 | 2009 | 352 | 0.530 |
Why?
| | Monosaccharides | 1 | 2015 | 12 | 0.490 |
Why?
| | Receptors, Fc | 1 | 2015 | 53 | 0.470 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 364 | 0.440 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 597 | 0.420 |
Why?
| | Immunoglobulin G | 3 | 2015 | 893 | 0.410 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.410 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1809 | 0.370 |
Why?
| | Pseudomonas Vaccines | 1 | 2009 | 1 | 0.320 |
Why?
| | Escherichia coli | 2 | 2025 | 815 | 0.310 |
Why?
| | Peptides | 3 | 2009 | 985 | 0.280 |
Why?
| | Vaccines, Synthetic | 2 | 2007 | 126 | 0.280 |
Why?
| | Cell Line | 4 | 2018 | 2847 | 0.280 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 351 | 0.270 |
Why?
| | Fimbriae, Bacterial | 1 | 2007 | 34 | 0.270 |
Why?
| | Epithelial Cells | 3 | 2018 | 1096 | 0.260 |
Why?
| | Wound Healing | 3 | 2025 | 331 | 0.250 |
Why?
| | Pseudomonas Infections | 2 | 2007 | 225 | 0.250 |
Why?
| | Receptors, Cell Surface | 1 | 2007 | 385 | 0.240 |
Why?
| | Butyrates | 1 | 2025 | 61 | 0.220 |
Why?
| | Purines | 1 | 2025 | 176 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3566 | 0.210 |
Why?
| | Peptide Fragments | 1 | 2007 | 706 | 0.210 |
Why?
| | Mice | 9 | 2025 | 17787 | 0.210 |
Why?
| | Neutrophils | 3 | 2018 | 1238 | 0.200 |
Why?
| | NADH Dehydrogenase | 1 | 2022 | 19 | 0.190 |
Why?
| | Nucleosides | 1 | 2022 | 27 | 0.190 |
Why?
| | Guanosine Triphosphate | 1 | 2022 | 91 | 0.190 |
Why?
| | Mice, Knockout | 3 | 2017 | 3015 | 0.180 |
Why?
| | Microbial Sensitivity Tests | 1 | 2022 | 361 | 0.170 |
Why?
| | Animals | 14 | 2025 | 36940 | 0.170 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 491 | 0.160 |
Why?
| | Receptors, IgG | 2 | 2016 | 75 | 0.150 |
Why?
| | Tryptophan | 2 | 2017 | 183 | 0.150 |
Why?
| | Tight Junctions | 2 | 2018 | 76 | 0.150 |
Why?
| | Polyphosphates | 1 | 2018 | 37 | 0.150 |
Why?
| | Pyrophosphatases | 1 | 2018 | 28 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2017 | 72 | 0.150 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2018 | 46 | 0.150 |
Why?
| | Receptors, Interleukin-10 | 1 | 2018 | 7 | 0.140 |
Why?
| | Nucleotidases | 1 | 2017 | 7 | 0.140 |
Why?
| | Receptor, Cannabinoid, CB2 | 1 | 2017 | 11 | 0.140 |
Why?
| | Nucleotides | 1 | 2018 | 125 | 0.140 |
Why?
| | Cricetulus | 2 | 2015 | 109 | 0.140 |
Why?
| | Bacterial Load | 1 | 2017 | 68 | 0.140 |
Why?
| | CHO Cells | 2 | 2015 | 161 | 0.140 |
Why?
| | Signal Transduction | 4 | 2018 | 5079 | 0.130 |
Why?
| | Cricetinae | 2 | 2015 | 289 | 0.130 |
Why?
| | Interleukin-10 Receptor alpha Subunit | 1 | 2017 | 5 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2009 | 2139 | 0.130 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 56 | 0.130 |
Why?
| | Immune Complex Diseases | 1 | 2016 | 8 | 0.130 |
Why?
| | Protein Binding | 2 | 2015 | 2224 | 0.130 |
Why?
| | Molecular Sequence Data | 4 | 2009 | 2900 | 0.130 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2015 | 8 | 0.120 |
Why?
| | Antigens, CD20 | 1 | 2015 | 29 | 0.120 |
Why?
| | Complement C1q | 1 | 2015 | 37 | 0.120 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 84 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2017 | 183 | 0.120 |
Why?
| | Glycoside Hydrolases | 1 | 2015 | 26 | 0.120 |
Why?
| | Inflammation | 2 | 2017 | 2837 | 0.120 |
Why?
| | Glycopeptides | 1 | 2015 | 43 | 0.120 |
Why?
| | Electrochemical Techniques | 1 | 2016 | 54 | 0.120 |
Why?
| | Glycosylation | 1 | 2015 | 151 | 0.120 |
Why?
| | Claudin-1 | 1 | 2015 | 15 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5757 | 0.110 |
Why?
| | Indoles | 1 | 2018 | 412 | 0.110 |
Why?
| | Crohn Disease | 1 | 2017 | 243 | 0.110 |
Why?
| | Adenine | 1 | 2016 | 271 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 558 | 0.100 |
Why?
| | Amino Acids | 1 | 2016 | 497 | 0.090 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2015 | 375 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2017 | 922 | 0.090 |
Why?
| | Microbiota | 1 | 2018 | 762 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 385 | 0.080 |
Why?
| | Protein Structure, Secondary | 2 | 2007 | 374 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4295 | 0.080 |
Why?
| | Vaccines, Conjugate | 1 | 2009 | 65 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 861 | 0.080 |
Why?
| | Kidney | 1 | 2016 | 1468 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1547 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2016 | 4193 | 0.070 |
Why?
| | Surface Plasmon Resonance | 2 | 2006 | 87 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3412 | 0.070 |
Why?
| | Dextran Sulfate | 2 | 2018 | 83 | 0.070 |
Why?
| | Crystallization | 1 | 2007 | 143 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 239 | 0.070 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 127 | 0.070 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1272 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1353 | 0.060 |
Why?
| | Viral Envelope Proteins | 1 | 2006 | 84 | 0.060 |
Why?
| | Models, Molecular | 2 | 2007 | 1570 | 0.060 |
Why?
| | Immunization | 1 | 2007 | 411 | 0.060 |
Why?
| | Humans | 9 | 2018 | 137585 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2007 | 611 | 0.060 |
Why?
| | Bacterial Vaccines | 1 | 2004 | 63 | 0.060 |
Why?
| | Antibodies, Bacterial | 1 | 2004 | 146 | 0.050 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 697 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 500 | 0.050 |
Why?
| | Homeostasis | 2 | 2018 | 621 | 0.050 |
Why?
| | Cell Movement | 2 | 2018 | 967 | 0.050 |
Why?
| | Survival Rate | 1 | 2007 | 1972 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2017 | 1250 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 8 | 0.040 |
Why?
| | Tight Junction Proteins | 1 | 2018 | 15 | 0.040 |
Why?
| | Dinucleoside Phosphates | 1 | 2018 | 27 | 0.040 |
Why?
| | Ileum | 1 | 2017 | 119 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 1 | 2016 | 46 | 0.030 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2017 | 55 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 305 | 0.030 |
Why?
| | Antigen-Antibody Complex | 1 | 2016 | 90 | 0.030 |
Why?
| | Kynurenine | 1 | 2017 | 114 | 0.030 |
Why?
| | Intestines | 1 | 2018 | 357 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 347 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 138 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2017 | 302 | 0.030 |
Why?
| | Cell Communication | 1 | 2016 | 315 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1007 | 0.030 |
Why?
| | Monocytes | 1 | 2016 | 563 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2017 | 789 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 378 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1457 | 0.020 |
Why?
| | Female | 2 | 2017 | 73304 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2016 | 785 | 0.020 |
Why?
| | Hypoxia | 1 | 2017 | 1112 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3556 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2607 | 0.020 |
Why?
| | Neutralization Tests | 1 | 2006 | 75 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2006 | 149 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2006 | 189 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2006 | 178 | 0.010 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2006 | 109 | 0.010 |
Why?
| | Male | 2 | 2025 | 67762 | 0.010 |
Why?
| | Antibody Affinity | 1 | 2004 | 60 | 0.010 |
Why?
| | Cross Reactions | 1 | 2004 | 133 | 0.010 |
Why?
| | Vaccines, Subunit | 1 | 2004 | 49 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 852 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1226 | 0.010 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 216 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 794 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1670 | 0.010 |
Why?
| | Ligands | 1 | 2004 | 664 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1178 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 33479 | 0.010 |
Why?
|
|
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|